Sign in

NCT07318220Recruiting

Prehabilitation Protocol for Head and Neck Cancer Patients

Optimizing Cancer Support Services Usage in Patients With Head and Neck Cancer During the Prehabilitation Period

Source: ClinicalTrials.gov · Last updated 1 Sept 2026

Brief summary (registry, in English)

The purpose of this research is to help researchers understand the barriers, supports, and preferences for prehabilitation. Prehabilitation in this study means head and neck cancer patients will receive nutritional counseling sessions and attend exercise programs before and during radiotherapy/chemoradiotherapy treatment.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
22 Dec 2025
Start date
1 May 2026
Primary completion date
30 Aug 2027
Lead sponsor
University of Miami
NCT number
NCT07318220

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 May 2026 to the primary completion date, 30 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Aim 2 Inclusion Criteria: Implement prehabilitation prescription protocol and evaluate the feasibility and acceptability of the prehabilitation prescription protocol in a sample of HNC patients.
  • Age 18 to 80 years old
  • Patients with a diagnosis of squamous cell carcinoma originating in the head and neck (oral cavity, oropharynx, hypopharynx, larynx, and nasopharynx).
  • Stage I-III or de novo Stage IV
  • Patients with a plan for radiation therapy (RT) / chemoradiation therapy (CRT) at SCCC\* - \*Patients who underwent surgery for the HNC are still eligible.
  • If this is a second primary squamous cell carcinoma originating in the head and neck, a patient is eligible if the last RT or CRT was completed more than 6 months ago.
  • Clearance for exercise by the medical team.
  • Patients who do not have their first treatment scheduled within 7 days at the time of recruitment.
  • An English or Spanish speaker.
    • Aim 2 Exclusion Criteria:
  • A patient who cannot complete the baseline assessment and/or start prehabilitation by the initiation of RT/CRT.
  • Any contraindication for diet change or exercising as determined by a physician.
  • A patient who is not an English or Spanish speaker.
  • History of dementia or major psychiatric disease which would interfere with study.
  • History of recent (≤1 yr) stroke, myocardial infarction, or congestive heart failure
  • Eastern Cooperative Oncology Group (ECOG) equal to or higher than 2.

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Miami
Coordinator of this site? Confirm its status
MiamiUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.